RTALB Share Price Performance
Recent RTALB News & Updates
No updates
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.19
- Gross Margin
- 27.44%
- Net Profit Margin
- 55.16%
- Debt/Equity Ratio
- 8.2%
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Competitors
About RTALB
- Founded
- 1996
- Employees
- 87
- CEO
- WebsiteView website
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.
Turkish Market Performance
- 7 Days: 3.7%
- 3 Months: 23.7%
- 1 Year: 7.7%
- Year to Date: 18.4%
The market is up 3.7% over the last week, with the Financials sector leading the way, up 9.1%. In the last year, the market has climbed 7.7%. Earnings are forecast to grow by 34% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading